Does C-reactive protein predict time to recovery and benefit from oseltamivir treatment in primary care patients with influenza-like illness? A randomized controlled trial secondary analysis

OBJECTIVE: Recovery time and treatment effect of oseltamivir in influenza-like illness (ILI) differs between patient groups. A point-of-care test to better predict ILI duration and identify patients who are most likely to benefit from oseltamivir treatment would aid prescribing decisions in primary...

Descripción completa

Detalles Bibliográficos
Autores principales: Harbin, Nicolay Jonassen, Rystedt, Karin, Lindbaek, Morten, Radzeviciene, Ruta, Westin, Johan, Gunnarsson, Ronny, Butler, Christopher C., van der Velden, Alike W., Verheij, Theo J., Sundvall, Pär-Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725887/
https://www.ncbi.nlm.nih.gov/pubmed/34850657
http://dx.doi.org/10.1080/02813432.2021.2006482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725887/
https://www.ncbi.nlm.nih.gov/pubmed/34850657
http://dx.doi.org/10.1080/02813432.2021.2006482

Ejemplares similares